血液病患者跌倒风险预测模型的开发和内部验证:一项队列研究。

IF 2.3 4区 医学 Q2 HEMATOLOGY Expert Review of Hematology Pub Date : 2024-04-01 Epub Date: 2024-03-14 DOI:10.1080/17474086.2024.2329596
Huang Xinrui, Xu Min, Cao Min, Xu Chenyi
{"title":"血液病患者跌倒风险预测模型的开发和内部验证:一项队列研究。","authors":"Huang Xinrui, Xu Min, Cao Min, Xu Chenyi","doi":"10.1080/17474086.2024.2329596","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To develop and internally validate a prediction model for identifying patients with hematologic diseases of fall risk.</p><p><strong>Research design and methods: </strong>This is a prospective cohort study from a prospective collection of data for 6 months. We recruited 412 patients with hematologic diseases in medical institutions and home environment of China. The outcome of the prediction model was fall or not. These variables were filtered via univariable logistic analysis, LASSO, and multivariable logistic analysis. We adopt an internal validation method of K-fold cross validation. The area under the ROC curve and the H-L test were used to evaluate the discrimination and calibration of the model.</p><p><strong>Results: </strong>Five influencing factors were identified multivariable logistic regression analysis. The established model equation is as follows: the H-L goodness-of-fit test of the model <i>p</i> > 0.05. The area under the ROC curve of train is 0.957 (95% CI: 0.936 ~ 0.978), and the area under the ROC curve of test is 0.962 (95% CI: 0.884 ~ 1), so the model calibration and discriminant validity are good.</p><p><strong>Conclusion: </strong>Our equation has good sensitivity and specificity in predicting the fall risk of patients with hematologic diseases, and has certain positive significance for clinical assessment of their fall risk.</p><p><strong>Trial registration number: </strong>ChiCTR2200063940.</p>","PeriodicalId":12325,"journal":{"name":"Expert Review of Hematology","volume":" ","pages":"135-143"},"PeriodicalIF":2.3000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study.\",\"authors\":\"Huang Xinrui, Xu Min, Cao Min, Xu Chenyi\",\"doi\":\"10.1080/17474086.2024.2329596\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To develop and internally validate a prediction model for identifying patients with hematologic diseases of fall risk.</p><p><strong>Research design and methods: </strong>This is a prospective cohort study from a prospective collection of data for 6 months. We recruited 412 patients with hematologic diseases in medical institutions and home environment of China. The outcome of the prediction model was fall or not. These variables were filtered via univariable logistic analysis, LASSO, and multivariable logistic analysis. We adopt an internal validation method of K-fold cross validation. The area under the ROC curve and the H-L test were used to evaluate the discrimination and calibration of the model.</p><p><strong>Results: </strong>Five influencing factors were identified multivariable logistic regression analysis. The established model equation is as follows: the H-L goodness-of-fit test of the model <i>p</i> > 0.05. The area under the ROC curve of train is 0.957 (95% CI: 0.936 ~ 0.978), and the area under the ROC curve of test is 0.962 (95% CI: 0.884 ~ 1), so the model calibration and discriminant validity are good.</p><p><strong>Conclusion: </strong>Our equation has good sensitivity and specificity in predicting the fall risk of patients with hematologic diseases, and has certain positive significance for clinical assessment of their fall risk.</p><p><strong>Trial registration number: </strong>ChiCTR2200063940.</p>\",\"PeriodicalId\":12325,\"journal\":{\"name\":\"Expert Review of Hematology\",\"volume\":\" \",\"pages\":\"135-143\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17474086.2024.2329596\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474086.2024.2329596","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

研究背景研究设计与方法:这是一项为期6个月的前瞻性队列研究。我们在中国的医疗机构和家庭环境中招募了 412 名血液病患者。预测模型的结果是跌倒与否。这些变量通过单变量逻辑分析、LASSO 和多变量逻辑分析进行筛选。我们采用了 K 倍交叉验证的内部验证方法。使用 ROC 曲线下面积和 H-L 检验来评估模型的区分度和校准:结果:通过多变量逻辑回归分析确定了五个影响因素。建立的模型方程为:模型的 H-L 拟合度检验 p > 0.05。训练的 ROC 曲线下面积为 0.957(95% CI:0.936 ~ 0.978),检验的 ROC 曲线下面积为 0.962(95% CI:0.884 ~ 1),因此模型校准和判别有效性良好:结论:我们的方程在预测血液病患者跌倒风险方面具有良好的灵敏度和特异性,对临床评估其跌倒风险具有一定的积极意义:ChiCTR2200063940。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study.

Background: To develop and internally validate a prediction model for identifying patients with hematologic diseases of fall risk.

Research design and methods: This is a prospective cohort study from a prospective collection of data for 6 months. We recruited 412 patients with hematologic diseases in medical institutions and home environment of China. The outcome of the prediction model was fall or not. These variables were filtered via univariable logistic analysis, LASSO, and multivariable logistic analysis. We adopt an internal validation method of K-fold cross validation. The area under the ROC curve and the H-L test were used to evaluate the discrimination and calibration of the model.

Results: Five influencing factors were identified multivariable logistic regression analysis. The established model equation is as follows: the H-L goodness-of-fit test of the model p > 0.05. The area under the ROC curve of train is 0.957 (95% CI: 0.936 ~ 0.978), and the area under the ROC curve of test is 0.962 (95% CI: 0.884 ~ 1), so the model calibration and discriminant validity are good.

Conclusion: Our equation has good sensitivity and specificity in predicting the fall risk of patients with hematologic diseases, and has certain positive significance for clinical assessment of their fall risk.

Trial registration number: ChiCTR2200063940.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.70
自引率
3.60%
发文量
98
审稿时长
6-12 weeks
期刊介绍: Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.
期刊最新文献
The impact of oral health promotion on the quality of life of children with bleeding disorders: fighting misconceptions. Rivaroxaban plus aspirin after lower-extremity revascularization. Current and emerging therapies as potential treatment for people with von Willebrand disease. Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators. BCL-2 inhibition in acute myeloid leukemia: resistance and combinations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1